top of page

Latest News

12.3.26

Hypermarker personalised trial gets the green light

Hypermarker aims to personalise hypertension treatment through metabolomics

Hypermarker personalised trial gets the green light

16.2.26

Fourth Hypermarker annual meeting in Leiden

Hypermarker Annual Meeting Brings Progress and Collaboration

Fourth Hypermarker annual meeting in Leiden

17.12.25

Introduction to the Hypermarker Randomised Clinical Trial

Hypermarker aims to personalise hypertension treatment through metabolomics

Introduction to the Hypermarker Randomised Clinical Trial

29.10.25

New insights from the Hypermarker team

New interview series released on our YouTube channel

New insights from the Hypermarker team

10.7.25

Hypermarker clinical trial design finalised with patient input

Trial to launch in four countries with strong focus on patient-informed design

Hypermarker clinical trial design finalised with patient input

Contact Information

 

For more details regarding the Hypermarker project, please reach out to Carl Steinbeisser via email or stay updated by following us on our social media platforms.

​

Email: carl [at] collaborate [dot] eu

EN_FundedbytheEU_RGB_POS.png
UKRI Logo

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

​

This work is also supported by the UKRI Horizon Europe Guarantee scheme.

  • LinkedIn
  • Youtube

© 2025 by Collaborate Project Management GmbH. 

bottom of page